Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema IBIO

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
16.04.iBio files to sell 10.57M shares of common stock for holders4
03.04.SLS, IBIO and ALDX are among premarket gainers9
01.04.iBio, Inc. - 8-K, Current Report3
27.03.iBio stock nearly tripled on Wednesday: here's why20
27.03.iBio climbs after AI-led drug discovery deal10
27.03.Why Is iBio (IBIO) Stock Up 125% Today?16
27.03.Micro-Cap Stock iBio Doubles On Wednesday - Here's Why5
27.03.IBio In Partnership With AstralBio; Shares Up In Pre-market9
27.03.Pre-market Movers: iBio, Direct Digital Holdings, Nuvation Bio, PaySign, LuxUrban Hotels304CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.30 A.M. ET).In the Green iBio, Inc. (IBIO) is up over 86% at $2.14. Nuvation...
► Artikel lesen
27.03.iBio, Inc.: iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases104- Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments - - iBio to use its patented generative AI/Machine Learning platform to discover, engineer...
► Artikel lesen
27.03.iBio announces $15 million private placement9
27.03.iBio, Inc.: iBio Announces $15.0 Million Private Placement8
26.02.iBio stock jumps on sale of preclinical PD-1 agonist antibody program10
26.02.iBio, Inc.: iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka682- Deal includes $1 million upfront and potential future milestone payments - - iBio's proprietary therapeutic pipeline will now be comprised entirely of promising immuno-oncology candidates - BRYAN...
► Artikel lesen
21.02.iBio, Inc. - 8-K, Current Report4
09.02.iBio, Inc. - 10-Q, Quarterly Report7
19.01.iBio, Inc. - 8-K, Current Report12
16.01.iBio, Inc.: iBio Announces Participation in 23rd Annual PepTalk Conference10
10.01.iBio, Inc. - S-8, Securities to be offered to employees in employee benefit plans7
08.01.iBio, Inc. - 8-K, Current Report6
Seite:  Weiter >>